Table of Contents

    Topic review

    STN DBS under General Anesthesia

    Subjects: Others
    View times: 52
    Submitted by: Hye Ran Park

    Definition

    Bilateral subthalamic nucleus (STN) Deep brain stimulation (DBS) is a well-established treatment in patients with Parkinson’s disease (PD). Traditionally, STN DBS for PD is performed by using microelectrode recording (MER) and/or intraoperative macrostimulation under local anesthesia (LA). However, many patients cannot tolerate the long operation time under LA without medication. In addition, it cannot be even be performed on PD patients with poor physical and neurological condition. Recently, it has been reported that STN DBS under general anesthesia (GA) can be successfully performed due to the feasible MER under GA, as well as the technical advancement in direct targeting and intraoperative imaging.

    1. Introduction

    Parkinson’s disease (PD) is the second most common neurodegenerative disease following Alzheimer’s disease, characterized by bradykinesia, rigidity, resting tremor and postural instability [1]. The long-term use of anti-Parkinsonian drugs has been found to be associated with dyskinesia and symptom fluctuation. Since the introduction of deep brain stimulation (DBS) in 1980s, DBS has been accepted as a preferred surgical treatment for PD [2]. Internal globus pallidus (GPi) and subthalamic nucleus (STN) are the main stimulation targets [3]. In particular, bilateral STN DBS is known to significantly improve not only primary motor symptoms, but also non-motor symptoms, such as sensory symptoms and sleep disturbances [4][5].

    Traditionally, DBS surgery is performed under local anesthesia (LA) and conscious sedation to evaluate clinical benefit and side effects by localizing electrophysiological target using microelectrode recording (MER) and/or intraoperative test stimulation while the patient is awake [6][7][8][9][10][11][12][13][14][15]. STN DBS has several advantages when implemented under LA. The spike features of MER can be analyzed, and symptom relief or side effects by stimulation can be evaluated with intraoperative macrostimulation. In addition, by using electrophysiological targeting using MER, it is possible to compensate for errors from planning based on preoperative imaging, which is caused by brain shift due to cerebrospinal fluid (CSF) leakage after dura opening. However, MER under LA requires PD patients to withstand surgical procedure with approximately 18 h of antiparkinsonian medication discontinued. Most PD patients are old age and have severe multiple neuro-skeleto-muscular symptoms due to comorbidity, such as spinal stenosis and herniated intervertebral disc. Moreover, patients have to wear a frame on their head during the entire procedure and undergo surgery with the frame fixed to the operation table; thus, the patients may suffer from intolerable pain and psychological sequelae. The risk of hemorrhage risk also increases if an unintended large motion occurs due to cough or tremor during surgery. Patient cooperation is one of the factors that may influence the outcome after surgery.

    Because of these concerns, many authors have consistently tried STN DBS under GA and reported that the clinical outcome is not inferior compared to under LA. However, there have been no randomized trials comparing DBS surgery under LA and GA due to logistical concerns. Only class II evidence has been compared through retrospective data analysis [16]. Here, we aimed to review previously published literature on STN DBS under GA as an alternative to STN DBS under LA. The technique and clinical outcome using intraoperative imaging and MER in DBS under GA are thoroughly reviewed along with the introduction of single-center experience of our institution.

    2. STN DBS Using Intraoperative Imaging or Microelectrode Recording Under GA

    The DBS surgical procedure can be divided into two stages: the intracranial implantation of DBS electrodes and the implantation of implantable pulse generator (IPG). In the case of IPG implantation, GA is generally preferred because tunneling is required subcutaneously. For intracranial electrode implantation, the STN DBS procedure under LA and GA are similar, but the specific details are different. The main difference between the STN DBS surgical procedure under LA and GA is the intraoperative verification method for the intended target acquisition, i.e., test stimulation or intraoperative imaging with or without MER. An accurate electrode location is a key factor to determine the postoperative prognosis after STN DBS surgery [17][18][19][20]. Image verification of the lead position is an important step, whether intra- or postoperatively [21]. For STN DBS under GA, some centers perform intraoperative verification using MER even under GA, and other centers use intraoperative imaging without MER. We reviewed each method of STN DBS under GA using intraoperative imaging or MER, respectively (Table 1).

    Table 1. Summary data of published literature presenting clinical outcome effect of after subthalamic nucleus deep brain stimulation under general anesthesia in patients with Parkinson’s disease.

    Author

    Year

    No. of Patients

    Age (yrs)

    Disease Duration (yrs)

    Follow-up Months

    UPDRS III Medication off

     

    LEDD

    Baseline

    Follow-up*

    % Change

    p-value

     

    Baseline

    Follow-up*

    % Change

    p - Value

    Intraoperative imaging

    Interventional MRI

    Starr et al.[22]

    2010

    29

    58 ± 8.1

    NR

    9

    49 ± 13

    19 ±14

    60%

    0.0001

     

    NR

    NR

    NR

    NR

    Foltynie et al. [23]

    2011

    79

    58.9± 7.7

    11.5 ± 7

    14

    51.5 ± 14.9

    23.8 ± 11.2

    52%

    0.0001

     

    NR

    NR

    NR

    NR

    Nakajima et al. [24]

    2011

    14

    56.1 ± 6.5

    13.8 ± 8.1

    12 ± 6.1

    57.9 ± 16.6

    27.3 ± 11.8

    53%

    0.0001

     

    1505 ± 764

    764 ± 435

    49.20%

    <0.01

    Ostrem et al. [25]

    2013

    17

    59.8

    11.1

    6

    44.5 ± NA

    22.5

    49.44%

    0.001

     

    1337 ± 482

    NR

    24.70%

    0.003

    Saleh et al. [26]

    2015

    14

    64 ± 11.9

    10.9 ± 3.8

    5.86 ± 1.15

    NR

    NR

    NR

    NR

     

    NR

    NR

    49.27%

    0.0031

    Ostrem et al. [27]

    2016

    20

    63.2 ± 6.8

    10.8 ± 2.9

    12

    40.75 ± 10.9

    24.35 ± 8.8

    40.20%

    0.001

     

    1072.5 ± 382

    828.25 ± 492

    21.13%

    0.046

    Sidiropoulous et al. [28]

    2016

    12

    64.7 ± 5.9

    11.9 ± 3.7

    13.5 ± 3.7

    37.2

    20.2

    46.2%

    0.03

     

    1458 ± 653

    1337 ± 733

    8.3%

    0.7

    Chircop et al. [29]

    2018

    26

    60.2 ± 9.3

    8.8 ± 2.7

    12

    45.9 ± 14.3

    26.7 ± 11.5

    41.70%

    <0.001

     

    863 ± 211

    599 ± 273

    30.60%

    <0.001

    Matias et al. [30]

    2018

    33

    67.2 ± 6.4

    12.7 ± 6.9

    9.1

    52.8 ± 14.9

    28.6 ± 11.9

    45.8%

    <0.001

     

    NR

    NR

    NR

    NR

    Intraoperative CT

    Mirzadeh et al. [31]

    2016

    35

    61.1

    10.7

    6

    48.4 ± 13.8

    28.9 ± 12.5

    40.30%

    <0.0001

     

    1207 ± 733

    1035 ± 478

    14%

    0.004

    Microelectrode recording

    Hertel et al. [32]

    2006

    9

    70.7 ± 3.6

    13.6 ± 6.0

    3

    43.0 ± NR

    19 ± NR

    55.80%

    NR

     

    NR

    NR

    NR

    NR

    Lefaucheur et al. [33]

    2008

    30

    57.7 ± 11.1

    14.0 ± 4.0

    12

    47.9 ± 13.6

    48.6 ± 19.0

    69.10%

    0.87

     

    1470.8 ± 729.5

    NR

    66.4 ± 17.2

    NR

    Lin et al. [34]

    2008

    10

    58.9 ± 9.9

    8.8 ± 3.7

    6

    50.2 ± 12.9

    25.6 ± 11.68

    48.85%

    <0.05

     

    NR

    NR

    NR

    NR

    Fluchere et al. [35]

    2014

    188

    61 ± 7

    12 ± 4

    12

    33.6 ± 13.3

    13.2 ± 9.1

    61.00%

    <0.001

     

    1173 ± 495

    636 ± 376

    46.00%

    <0.001

    This study

    2020

    90

    57.43 ± 7.85

    11.67 ± 4.75

    6

    38.11 ± 13.96

    21.48 ± 12.33

    43.60%

    <0.001

     

    1448.0 ± 546.93

    483.99 ± 330.42

    66.60%

    <0.001

    Data are presented as: mean ± standard deviation UPDRS, Unified Parkinson’s Disease Rating Scale; LEDD, Levodopa equivalent daily dose; NR, Not reported. * On stimulation.

    2.1. Using Intraoperative Imaging

    With the development of the quality of magnetic resonance imaging (MRI) over the past decades, it has become feasible to identify the STN boundary can to easily implement DBS under GA using direct targeting using advanced imaging [36]. The combination of direct targeting based on MRI visualization of anatomical structures and intraoperative imaging used to confirm accurate lead placement enables surgeons to accurately identify STN targets. It may allow STN DBS procedure to be performed in an asleep state under general anesthesia (GA) without neurophysiological test [37][38][39].

    Successful clinical results on the intraoperative imaging to verify the accuracy of STN lead position instead of electrophysiological structure mapping or stimulation tests during DBS surgery have been reported [40][41][42][43][44]. In recent studies on the advancement of intraoperative imaging, no significant clinical results were found when compared to awake DBS [45][46]. However, most of these studies are retrospective analyses with a small number of patients and significant heterogeneity in anesthesia and surgical techniques. In addition, most of the studies were conducted in highly specialized centers with considerable experience in intraoperative imaging. Although these results may not be generalized to all DBS centers for these reasons, current results of STN DBS under GA are promising.

    2.1.1. Intraoperative CT

    In some centers, intraoperative computed tomography (iCT) during surgery is used to verify the accuracy of lead placement (Table 1). This is achieved through fusion of iCT scans and preoperative MRI scans after intracranial electrode implantation [47]. In awake DBS surgery with MER guidance, iCT provides useful information, such as hemorrhage and a general idea of electrode location when fused with preoperative MRI. According to a study about the accuracy of microelectrode trajectory in patients receiving MER-guided awake DBS using iCT, median (IQR) radial error 0.59 (0.64) mm, and median (IQR) absolute x and y coordinate errors were 0.29 (0.52) and 0.38 (0.44) mm, respectively. Burchiel et al. fused and compared iCT and trajectory planning images after electrode implantation for various targets. The mean vector error and mean deviation of trajectory was 1.59 ± 1.11 mm and 1.24 ± 0.87 mm, respectively, and the intraoperative replacement was performed on one electrode with a vector error of more than 3 mm. There was a significant correlation between the distance from the ventricle and the error. Kremer et al. stated that the mean difference between lead tips was 0.98 ± 0.49 mm, and the upper confidence interval did not exceed the non-inferiority margin described when comparing postoperative MRI with iCT [48].

    Some centers use MER without test stimulation but with intraoperative imaging to verify the intended target acquisition in STN DBS surgery under GA [49][50][51][52][53][54][55][56][57][58]. A recent study compared the mean errors of MER-guided electrode implantation in DBS surgery under LA and those of iCT scan-guided intracranial electrode implantation in STN DBS surgery under GA. When targeting STN, mean radial errors of the LA and GA group was about 0.9 ± 0.3 mm without significant difference (P = 0.70). The average number of brain penetration for electrode implantation in DBS surgery under LA and GA was similar (1.1 ± 0.2 and 1.1 ± 0.3 penetrations, p = 0.97). Brodsky et al. compared 6-months of the clinical outcomes between the group of LA and GA with iCT [59]. There was no significant difference in the improvement in UPDRS III and II, but the improvement in summary index (p = 0.004), subscores for cognition (p = 0.011), communication (p < 0.001), and speech outcome (category, p = 0.0012; phonemic fluency, p = 0.038) was found better in the GA group.

    A few authors have published the results of a study using the intraoperative O-arm. Sharma et al. performed STN DBS surgery under GA using intraoperative O-arm without MER for various targets, and no significant targeting error due to incorporation of iCT images into preoperative CT or MRI was observed [60]. Carlson et al. also reported that intraoperative O-arm images provided a higher accuracy in determining the location of STN DBS electrodes than postoperative CT and MRI images [61].

    2.1.2. Intraoperative MRI

    Other centers use intraoperative (interventional) MRI (iMRI) to guide DBS electrode placement to the STN (Table 1) [62][63][64]. For example, the UCSF group reported their experience about bilateral STN DBS in PD patients using a first-generation MRI system (Nexframe, high-field interventional MR-imaging)  and ClearPoint system (ClearPoint interventional MRI) . There have been few published studies on the use of intraoperative MRI [62][63][64][65][66][67]. One of the reported advantages of iMRI is that it provides a real-time image acquisition to prospectively guided both trajectory planning and intended target verification prior to electrode placement [66]. Therefore, iMRI is one of the most useful methods for DBS targeting that allows precise validation of the real location of electrodes relative to the intended targets [66].

    Researches using iMRI with or without stereotactic frame have shown that an accuracy of less than 1 mm can be achieved with mean error close to 0.7 ± 0.3 mm [66]. The main advantage of electrode implantation using iMRI is that electrode trajectory can be accurately implanted and adjusted before final placement by visualizing the intended target [66]. The error after correcting the electrode location using iMRI under GA without MER was similar to the error of using MER . When comparing the electrode location on both sides, the error was smaller in the second insertion side than in the first insertion side, which is presumed to be due to the correction based on the iMRI result after the first insertion. Sidiropoulos et al. performed STN and GPi DBS surgery in advanced PD patients using the ClearPoint system and found that the mean radial error was 1.2 ± 0.7 mm in the STN group and 0.8 ± 0.3 mm in the GPi group . Starr et al. et al. demonstrated a significantly lower rate of radial error compared to when inserted using the traditional frame-based stereotaxy (3.1 ± 1.41 mm) in the iMRI-guided placement group (1.2 ± 0.65 mm) through burr hole-mounted trajectory guide . They explained that the possibility of brain shift-related errors was reduced because iMRI was performed after burr hole creation and intracranial air flow. Clinically, the UPDRS III “off” medication score and LEDD improved one year after surgery with iMRI .

    2.1.3. Targeting Accuracy

    The theoretical assumption of STN DBS under GA surgery is that the accuracy in targeting STN is not less and the results are better than STN DBS surgery under LA using MER. Kochanski et al. analyzed MER trajectories after STN DBS using 227 iCTs and found that 1.2 ± 0.2mm of radial error occurred in comparison with the location of the intended targets [68]. These errors may be related to the mechanical errors related with the frame, arc, guide tube, and frame, which can lead to lead deviation [69]. In a large-scale study of DBS patients who underwent surgery using iCT, there were greater Euclidean error and greater medial deviation in the trajectory targeting Vim. The authors found that there are systematic tendencies in stereotactic error that differ with respect to the structure targeted [70]. In the study analyzing stereotactic accuracy of iMRI, the DBS lead placement using iMRI guidance showed a radial targeting error of 0.6–1.2 mm, while the error using iCT was 0.8–1.24 mm [71]. STN DBS surgery under GA using confirmatory iCT is based on the assumption that CT-MRI merge was performed correctly, but there may be some errors in the fusion of imaging modality, which may lead to suboptimal targeting [72][73]. The advantage of STN DBS surgery with iMRI guidance is that it has less dependence on image fusion and can reflect brain shift after dura opening. Analysis of the iMRI study revealed that the deep brain structure moves about 2 mm after opening the dura [74].

    2.2. Using Microelectrode Recording

    2.2.1. Is MER Mandatory for STN DBS Surgery?

    In the standard STN DBS procedure under LA, MER is used during surgery to obtain a signal to identify the deep structure [75]. The final site of electrode implantation is determined by considering both MER and intraoperative test stimulation . Sedative drugs, such as propofol, dexmedetomidine, and remifentanil, are given to patients when it is not necessary for them to be awake [76][77]. The goal of using MER in STN DBS surgery is to obtain high accuracy in radiographic and neurophysiological targeting. Theoretically, the ideal target should be one and the same, but several important factors can lead to errors in targeting, resulting in inconsistency between optimal radiographic and neurophysiological targets. In the report on awake STN DBS, about 25% (38/150) of the electrodes were found very accurately located on the intended target very accurately with an error of less than 1mm, but electrophysiological recording did not match with the target in MER and/or intraoperative stimulation, or showed an unacceptably low side-effect threshold by stimulation. Although these findings may be explained by brain shifts, these cases indicate that MER is essential for target confirmation during DBS surgery. Even small merge error combined with brain shift can lead to discrepancies between optimal radiographic and neurophysiological targets [78][79][80]. The advantage of this method is that it is possible to observe the changes in MER related to passive motion during surgery, and immediately evaluate the effects and side effects through test stimulation [81]. By reflecting this result and modifying the electrode position, the effect can be maximized while the complications of stimulation can be minimized.

    MER signals may be mixed with many noises which may be caused by snoring or movements of the patient. The reliability and usefulness of MER during STN DBS surgery under LA are still being investigated. However, awake surgery may not be possible for some patients with severe anxiety, fear, reduced cooperation, severe pain, respiration difficulties and so on.

    MER may increase the risk of intracranial hemorrhage and cognitive decline [82]. Binder et al. reported a bleeding rate of 3.3% and a risk of permanent defects 0.6% [83]. The number of MER trajectory was found slightly higher in patients with hemorrhage without statistical significance than the patients without hemorrhage [84]. Some researchers have also questioned whether MER has a real significant impact on target refinement. They argued that a short MER-determined STN length alone cannot predict the occurrence of stimulation-related side effect [18]. Moreover, the MER procedure increases both surgical time and the cost [85].

    Macrostimulation test cannot be performed if the patients are asleep during the operation. There is also controversy about whether intraoperative stimulation is needed during DBS surgery. Some researchers believe that it is necessary to confirm the effectiveness of the stimulus. On the other hand, some argued that discontinuation of the drug in LA makes the results less reliable, especially if it is not located in the correct position within the STN, the effect can be easily observed and difficult to distinguish from the lesion effect [86].

    Due to the improved image quality of preoperative imaging, determining the final electrode location by imaging alone without MER does not negatively affect motor improvement and LEDD, and does not aggravate surgical complications [24,26,29,42,87]. The UPDRS III reduction rate at postoperative 3 months was higher in the group of STN DBS under LA with MER cohort (p = 0.006), but there was no significant difference at 1 year (p = 0.18), as well as in dysarthria, capsular, oculomotor, and sensory side effects [87]. Chen et al. also reported that there was no difference in the UPDRS III reduction rate and score 6 months after STN DBS surgery between the MER group and the non-MER group. In addition to frequently used imaging sequences, direct targeting can be used with quantitative susceptibility mapping (QSM) and diffusion tensor imaging (DTI).

    2.2.2. Is MER Possible Under GA?

    STN DBS under GA has traditionally been used in patients who are unable to tolerate awake surgery including pediatric patients, or in patients who do not require clinical testing, such as obsessive-compulsive disorder or epilepsy. The biggest concern with STN DBS surgery under GA for movement disorder is the possibility of diminution of MER signals. A few small-sized retrospective studies have reported that MER obtained from STN, GPi, substantia nigra in STN DBS surgery under GA with both volatile and intravenous anesthetics in PD and dystonia patients showed no significant difference compared with patients awake during the procedure [88][89][90][91]. Notably, the neural activity of typical burst pattern disappeared when higher anesthetic doses were used. However, the results of these studies are controversial given the small sample size and heterogeneity of the anesthetic used. A prospective, double-blinded study is needed to compare the effects of anesthetic agents on MER quality in patients undergoing STN DBS surgery under GA.

    The next concern is that since intraoperative stimulation cannot be performed under GA, immediate response of clinical effects and adverse effects associated with stimulation cannot be assessed during the STN DBS surgery. Several trials of MER in deep sedation have been performed without intraoperative stimulation [89]. In these studies, propofol or remifentanil tended to interfere with the electrophysiological signal, but there were no significant differences in terms of exact targeting, clinical effectiveness, and adverse event profiles. Other authors also reported that although there was significant MER signal attenuation in deep sedation with propofol, it did not interfere with the optimal approach to the target [92][93].

    Although a few studies have previously investigated the effects of anesthetics on MER over the past 20 years, the exact effect has not been fully elucidated. Most studies were retrospective analyses with heterogeneity in the anesthesia protocol used and the patient population, and thus, no definitive conclusions could be drawn. Therefore, most of the knowledge revealed to date is derived from the case reports or small case series. During MER, background neuronal discharges and spike activity patterns are an important part of the precise localization of the target nucleus. Anesthetics have been shown to affect background activity and neuronal spike activity in a dose-dependent manner, primarily through activation of γ-aminobutyric acid (GABA) receptors. In addition,, anesthetics do not have the same effect on neuronal activity in various target nucleus. Since most anesthetics enhance the inhibitory action of GABA, this difference in GABA-input of the target nucleus plays an important role [94][95].

    MER from STN in PD patients was successfully obtained under sedation with low-dose anesthetics. The anesthesia techniques used during MER ranged from conscious sedation with propofol, dexmedetomidine with no airway manipulation to GA with intravenous or inhalation anesthetics. Although anesthetics have been shown to reduce the spike activity, localization of the target areas was proven possible in most studies. Nevertheless, most studies did not mention the exact effect on the background activity, degree of suppression of spike activity, and the number of trajectories used for localization [96].

    Under desflurane inhalation, Lin et al. observed that MER could be performed with a typical neuronal firing pattern and motion-related firing of STN, and the clinical results were similar in both groups [97].

    Our group performed MER and implantation by administering propofol and fentanyl for sedation under LA, and reported the effects of propofol and fentanyl on MER and the clinical outcome. The locations of all electrodes were positioned within the STN. The postoperative 6-months UPDRS II and III, total “off” scores, Hoehn and Yahr (H&Y) scale, Schwab-England ADL scale scores, and LEDD have been greatly improved [92][93].

    Although the effects of short-acting opioid receptor agonists, such as remifentanil, on MER are not well known, some data suggest that GABAergic neurons may play a central role [98]. A few reports showed that anesthesia using propofol reduces the firing rate of basal ganglia in a few reports [99], while one study showed no significant difference in firing rate compared to LA when administered with propofol and fentanyl [92]. Monitored anesthesia using propofol appears to be a safe technique for DBS procedure [100]. In some studies, MER was properly performed without affecting the surgical outcome only when remifentanil administration was discontinued and propofol was carefully monitored [101]. However, the spontaneous firing patterns of STN and substantia nigra remained similar to those under LA [101]. Chen et al. also reported that there was no significant difference between the GA and LA groups in terms of MER trajectory, recorded STN depths, postoperative coordinates, and overall incidence of stimulation-related side effect. Under remifentanil or ketamine anesthesia, no significant differences were found in number of spikes detected, mean firing rate, pause index, and burst index compared to LA. However, Moll et al. observed a long interburst between abnormally long group discharges under propofol and remifentanil.

    Benzodiazepines are direct GABA-agonists, which can completely eliminate MER and cause dyskinesia. Dexmedetomidine may be a better alternative for anxiety relief. The effect of dexmedetomidine on neural activity has not been fully elucidated, but it seems to be a reasonable option due to the non-GABA-mediated mechanism of action. Several studies to date have shown minimal effects of low-dose dexmedetomidine on MER in STN and GPi [102][103][104][105]. Some authors reported that low doses of dexmedetomidine (<0.5 μg/kg/h) did not significantly affect the quality of MER in STN or GPi [104]. Although dexmedetomidine may affect the MER result, it does not affect target localization.

    2.2.3. Clinical Experiences of STN DBS Using MER Under GA

    Some authors performed STN DBS surgery on PD patients under GA and reported favorable clinical outcomes (Table 1). Hertel et al. reported that patients’ daily off phases decreased from 50% to 17%, while the Unified Parkinson’s Disease Rating Scale (UPDRS) III score was reduced from 43 (preoperative; medication off) to 19 (stimulation on; medication off) and 12 (stimulation on; medication on). Yamada et al. also reported that UPDRS II, III, IV on and off scores were significantly lower in the LA and GA groups at 3 months postoperatively, and the activities of daily living(ADL)s and motor symptoms, such as bradykinesia, tremor, rigidity, and axial symptoms, have improved significantly . In this study, a reduction in dyskinesia duration (p < 0.001), disability (p = 0.009) and off period duration, and improvement of sleep disorders were observed. Other authors also reported significant improvement in off-medication UPDRS, levodopa-equivalent daily dose (LEDD), and quality of life. Harries et al. reported a long-term clinical outcome of more than 5 years. In their study, not only the UPDRS II and III off score, but also the total UPDRS off scores at postoperative 1 year improved significantly, and the total UPDRS score continued to improve for up to 7 years.

    Previously, authors have suggested the use of bispectral analysis (BIS) of the electroencephalogram in STN DBS surgery under GA using MER. An appropriate MER signal can be easily obtained by adjusting the anesthesia depth using BIS [106]. BIS of 65–85 and 40–65 is recommended for sedation and GA, respectively [107]. In the case of sedation using dexmedetomidine, it has been reported that the MER signal does not differ from the nonsedated state if the BIS value is maintained below 80.

    The entry is from 10.3390/jcm9093044

    References

    1. Han, M.; Nagele, E.; DeMarshall, C.; Acharya, N.; Nagele, R. Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera. PloS one 2012, 7, e32383.
    2. Benabid, A.-L.; Pollak, P.; Louveau, A.; Henry, S.; De Rougemont, J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Stereotactic and functional neurosurgery 1987, 50, 344-346.
    3. Fasano, A.; Daniele, A.; Albanese, A. Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation. The Lancet Neurology 2012, 11, 429-442.
    4. Kleiner‐Fisman, G.; Herzog, J.; Fisman, D.N.; Tamma, F.; Lyons, K.E.; Pahwa, R.; Lang, A.E.; Deuschl, G. Subthalamic nucleus deep brain stimulation: summary and meta‐analysis of outcomes. Movement disorders: official journal of the Movement Disorder Society 2006, 21, S290-S304.
    5. Kim, H.-J.; Jeon, B.S.; Paek, S.H. Nonmotor symptoms and subthalamic deep brain stimulation in Parkinson’s disease. Journal of Movement Disorders 2015, 8, 83.
    6. Rezai, A.R.; Kopell, B.H.; Gross, R.E.; Vitek, J.L.; Sharan, A.D.; Limousin, P.; Benabid, A.L. Deep brain stimulation for Parkinson's disease: surgical issues. Mov Disord 2006, 21 Suppl 14, S197-218, doi:10.1002/mds.20956.
    7. Lyons, M.K.; Ziemba, K.; Evidente, V. Multichannel microelectrode recording influences final electrode placement in pallidal deep brain stimulation for Parkinson's disease: report of twenty consecutive cases. Turkish Neurosurgery 2011, 21, 555-558.
    8. Kinfe, T.M.; Vesper, J. The impact of multichannel microelectrode recording (MER) in deep brain stimulation of the basal ganglia. In Stereotactic and functional neurosurgery, Springer: 2013; pp. 27-33.
    9. Chen, S.-Y.; Lee, C.-C.; Lin, S.-H.; Hsin, Y.-L.; Lee, T.-W.; Yen, P.-S.; Chou, Y.-C.; Lee, C.-W.; Hsieh, W.A.; Su, C.-F. Microelectrode recording can be a good adjunct in magnetic resonance image–directed subthalamic nucleus deep brain stimulation for parkinsonism. Surgical neurology 2006, 65, 253-260.
    10. Chang, W.S.; Kim, H.Y.; Kim, J.P.; Park, Y.S.; Chung, S.S.; Chang, J.W. Bilateral subthalamic deep brain stimulation using single track microelectrode recording. Acta neurochirurgica 2011, 153, 1087-1095.
    11. Tsai, S.-T.; Hung, H.-Y.; Lee, C.-H.; Chen, S.-Y. Letter to the Editor: Deep brain stimulation and microelectrode recording. Journal of Neurosurgery 2014, 120, 580-580.
    12. Machado, A.; Rezai, A.R.; Kopell, B.H.; Gross, R.E.; Sharan, A.D.; Benabid, A.L. Deep brain stimulation for Parkinson's disease: surgical technique and perioperative management. Mov Disord 2006, 21 Suppl 14, S247-258, doi:10.1002/mds.20959.
    13. Priori, A.; Egidi, M.; Pesenti, A.; Rohr, M. Do intraoperative microrecordings improve subthalamic nucleus targeting in stereotactic neurosurgery for Parkinson's disease? Journal of neurosurgical sciences 2003, 47, 56.
    14. Benazzouz, A.; Breit, S.; Koudsie, A.; Pollak, P.; Krack, P.; Benabid, A.L. Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society 2002, 17, S145-S149.
    15. Su, X.-L.; Luo, X.-G.; Lv, H.; Wang, J.; Ren, Y.; He, Z.-Y. Factors predicting the instant effect of motor function after subthalamic nucleus deep brain stimulation in Parkinson’s disease. Translational neurodegeneration 2017, 6, 14.
    16. Ho, A.L.; Ali, R.; Connolly, I.D.; Henderson, J.M.; Dhall, R.; Stein, S.C.; Halpern, C.H. Awake versus asleep deep brain stimulation for Parkinson's disease: a critical comparison and meta-analysis. J Neurol Neurosurg Psychiatry 2018, 89, 687-691, doi:10.1136/jnnp-2016-314500.
    17. Saint-Cyr, J.A.; Hoque, T.; Pereira, L.C.; Dostrovsky, J.O.; Hutchison, W.D.; Mikulis, D.J.; Abosch, A.; Sime, E.; Lang, A.E.; Lozano, A.M. Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging. J Neurosurg 2002, 97, 1152-1166, doi:10.3171/jns.2002.97.5.1152.
    18. McClelland, S., 3rd; Ford, B.; Senatus, P.B.; Winfield, L.M.; Du, Y.E.; Pullman, S.L.; Yu, Q.; Frucht, S.J.; McKhann, G.M., 2nd; Goodman, R.R. Subthalamic stimulation for Parkinson disease: determination of electrode location necessary for clinical efficacy. Neurosurg Focus 2005, 19, E12.
    19. Zonenshayn, M.; Rezai, A.R.; Mogilner, A.Y.; Beric, A.; Sterio, D.; Kelly, P.J. Comparison of anatomic and neurophysiological methods for subthalamic nucleus targeting. Neurosurgery 2000, 47, 282-292; discussion 292-284, doi:10.1097/00006123-200008000-00005.
    20. Lanotte, M.M.; Rizzone, M.; Bergamasco, B.; Faccani, G.; Melcarne, A.; Lopiano, L. Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation. J Neurol Neurosurg Psychiatry 2002, 72, 53-58, doi:10.1136/jnnp.72.1.53.
    21. Bus, S.; Pal, G.; Ouyang, B.; van den Munckhof, P.; Bot, M.; Sani, S.; Verhagen Metman, L. Accuracy of Microelectrode Trajectory Adjustments during DBS Assessed by Intraoperative CT. Stereotact Funct Neurosurg 2018, 96, 231-238, doi:10.1159/000489945.
    22. Starr, P.A.; Martin, A.J.; Ostrem, J.L.; Talke, P.; Levesque, N.; Larson, P.S. Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy. J Neurosurg 2010, 112, 479-490, doi:10.3171/2009.6.Jns081161.
    23. Foltynie, T.; Zrinzo, L.; Martinez-Torres, I.; Tripoliti, E.; Petersen, E.; Holl, E.; Aviles-Olmos, I.; Jahanshahi, M.; Hariz, M.; Limousin, P. MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety. Journal of Neurology, Neurosurgery & Psychiatry 2011, 82, 358-363.
    24. Nakajima, T.; Zrinzo, L.; Foltynie, T.; Olmos, I.A.; Taylor, C.; Hariz, M.I.; Limousin, P. MRI-guided subthalamic nucleus deep brain stimulation without microelectrode recording: can we dispense with surgery under local anaesthesia? Stereotact Funct Neurosurg 2011, 89, 318-325, doi:10.1159/000330379.
    25. Ostrem, J.L.; Galifianakis, N.B.; Markun, L.C.; Grace, J.K.; Martin, A.J.; Starr, P.A.; Larson, P.S. Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement. Clinical neurology and neurosurgery 2013, 115, 708-712.
    26. Saleh, S.; Swanson, K.I.; Lake, W.B.; Sillay, K.A. Awake neurophysiologically guided versus asleep MRI-guided STN DBS for Parkinson disease: a comparison of outcomes using levodopa equivalents. Stereotactic and functional neurosurgery 2015, 93, 419-426.
    27. Ostrem, J.L.; Ziman, N.; Galifianakis, N.B.; Starr, P.A.; San Luciano, M.; Katz, M.; Racine, C.A.; Martin, A.J.; Markun, L.C.; Larson, P.S. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson’s disease. Journal of neurosurgery 2016, 124, 908-916.
    28. Sidiropoulos, C.; Rammo, R.; Merker, B.; Mahajan, A.; LeWitt, P.; Kaminski, P.; Womble, M.; Zec, A.; Taylor, D.; Wall, J. Intraoperative MRI for deep brain stimulation lead placement in Parkinson’s disease: 1 year motor and neuropsychological outcomes. Journal of neurology 2016, 263, 1226-1231.
    29. Chircop, C.; Dingli, N.; Aquilina, A.; Zrinzo, L.; Aquilina, J. MRI-verified "asleep" deep brain stimulation in Malta through cross border collaboration: clinical outcome of the first five years. Br J Neurosurg 2018, 32, 365-371, doi:10.1080/02688697.2018.1478061.
    30. Matias, C.M.; Frizon, L.A.; Nagel, S.J.; Lobel, D.A.; Machado, A.G. Deep brain stimulation outcomes in patients implanted under general anesthesia with frame-based stereotaxy and intraoperative MRI. Journal of Neurosurgery 2018, 129, 1572-1578.
    31. Mirzadeh, Z.; Chapple, K.; Lambert, M.; Evidente, V.G.; Mahant, P.; Ospina, M.C.; Samanta, J.; Moguel-Cobos, G.; Salins, N.; Lieberman, A., et al. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus. J Neurosurg 2016, 124, 902-907, doi:10.3171/2015.4.JNS1550.
    32. Hertel, F.; Züchner, M.; Weimar, I.; Gemmar, P.; Noll, B.; Bettag, M.; Decker, C. IMPLANTATION OF ELECTRODES FORDEEP BRAIN STIMULATION OF THE SUBTHALAMIC NUCLEUS IN ADVANCED PARKINSON'S DISEASE WITH THE AID OF INTRAOPERATIVE MICRORECORDING UNDERGENERAL ANESTHESIA. Neurosurgery 2006, 59, E1138-E1138.
    33. Lefaucheur, J.-P.; Gurruchaga, J.-M.; Pollin, B.; Von Raison, F.; Mohsen, N.; Shin, M.; Ménard-Lefaucheur, I.; Oshino, S.; Kishima, H.; Fénelon, G. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson’s disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia. European neurology 2008, 60, 186-199.
    34. Lin, S.H.; Chen, T.Y.; Lin, S.Z.; Shyr, M.H.; Chou, Y.C.; Hsieh, W.A.; Tsai, S.T.; Chen, S.Y. Subthalamic deep brain stimulation after anesthetic inhalation in Parkinson disease: a preliminary study. J Neurosurg 2008, 109, 238-244, doi:10.3171/JNS/2008/109/8/0238.
    35. Fluchere, F.; Witjas, T.; Eusebio, A.; Bruder, N.; Giorgi, R.; Leveque, M.; Peragut, J.C.; Azulay, J.P.; Regis, J. Controlled general anaesthesia for subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2014, 85, 1167-1173, doi:10.1136/jnnp-2013-305323.
    36. Patel, N.K.; Heywood, P.; O’Sullivan, K.; Love, S.; Gill, S.S. MRI-directed subthalamic nucleus surgery for Parkinson’s disease. Stereotactic and functional neurosurgery 2002, 78, 132-145.
    37. Burchiel, K.J.; McCartney, S.; Lee, A.; Raslan, A.M. Accuracy of deep brain stimulation electrode placement using intraoperative computed tomography without microelectrode recording. Journal of neurosurgery 2013, 119, 301-306.
    38. Mirzadeh, Z.; Chapple, K.; Lambert, M.; Dhall, R.; Ponce, F.A. Validation of CT‐MRI fusion for intraoperative assessment of stereotactic accuracy in DBS surgery. Movement Disorders 2014, 29, 1788-1795.
    39. Zrinzo, L.; Foltynie, T.; Limousin, P.; Hariz, M. Image‐guided and image‐verified deep brain stimulation. Movement Disorders 2013, 28, 254-254.
    40. Ferroli, P.; Franzini, A.; Marras, C.; Maccagnano, E.; D’Incerti, L.; Broggi, G. A simple method to assess accuracy of deep brain stimulation electrode placement: pre-operative stereotactic CT+ postoperative MR image fusion. Stereotactic and functional neurosurgery 2004, 82, 14-19.
    41. Fiegele, T.; Feuchtner, G.; Sohm, F.; Bauer, R.; Anton, J.V.; Gotwald, T.; Twerdy, K.; Eisner, W. Accuracy of stereotactic electrode placement in deep brain stimulation by intraoperative computed tomography. Parkinsonism & related disorders 2008, 14, 595-599.
    42. Chen, T.; Mirzadeh, Z.; Chapple, K.M.; Lambert, M.; Shill, H.A.; Moguel-Cobos, G.; Troster, A.I.; Dhall, R.; Ponce, F.A. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease. J Neurosurg 2018, 130, 109-120, doi:10.3171/2017.8.JNS17883.
    43. Ko, A.L.; Magown, P.; Ozpinar, A.; Hamzaoglu, V.; Burchiel, K.J. Asleep Deep Brain Stimulation Reduces Incidence of Intracranial Air during Electrode Implantation. Stereotact Funct Neurosurg 2018, 96, 83-90, doi:10.1159/000488150.
    44. Cui, Z.; Pan, L.; Song, H.; Xu, X.; Xu, B.; Yu, X.; Ling, Z. Intraoperative MRI for optimizing electrode placement for deep brain stimulation of the subthalamic nucleus in Parkinson disease. Journal of neurosurgery 2016, 124, 62-69.
    45. Chen, T.; Mirzadeh, Z.; Ponce, F.A. "Asleep" Deep Brain Stimulation Surgery: A Critical Review of the Literature. World Neurosurg 2017, 105, 191-198, doi:10.1016/j.wneu.2017.05.042.
    46. Sheshadri, V.; Rowland, N.C.; Mehta, J.; Englesakis, M.; Manninen, P.; Venkatraghavan, L. Comparison of General and Local Anesthesia for Deep Brain Stimulator Insertion: A Systematic Review. Can J Neurol Sci 2017, 44, 697-704, doi:10.1017/cjn.2017.224.
    47. Bot, M.; van den Munckhof, P.; Bakay, R.; Stebbins, G.; Metman, L.V. Accuracy of intraoperative computed tomography during deep brain stimulation procedures: comparison with postoperative magnetic resonance imaging. Stereotactic and functional neurosurgery 2017, 95, 183-188.
    48. Kremer, N.I.; Oterdoom, D.L.M.; van Laar, P.J.; Piña-Fuentes, D.; van Laar, T.; Drost, G.; van Hulzen, A.L.J.; van Dijk, J.M.C. Accuracy of Intraoperative Computed Tomography in Deep Brain Stimulation-A Prospective Noninferiority Study. 2019, 22, 472-477, doi:10.1111/ner.12918.
    49. Harries, A.M.; Kausar, J.; Roberts, S.A.; Mocroft, A.P.; Hodson, J.A.; Pall, H.S.; Mitchell, R.D. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results. J Neurosurg 2012, 116, 107-113, doi:10.3171/2011.7.JNS11319.
    50. Kwon, W.K.; Kim, J.H.; Lee, J.H.; Lim, B.G.; Lee, I.O.; Koh, S.B.; Kwon, T.H. Microelectrode recording (MER) findings during sleep-awake anesthesia using dexmedetomidine in deep brain stimulation surgery for Parkinson's disease. Clin Neurol Neurosurg 2016, 143, 27-33, doi:10.1016/j.clineuro.2016.02.005.
    51. Warnke, P. Deep brain stimulation: awake or asleep: it comes with a price either way. J Neurol Neurosurg Psychiatry 2018, 89, 672, doi:10.1136/jnnp-2017-315710.
    52. Tsai, S.-T.; Kuo, C.-C.; Chen, T.-Y.; Chen, S.-Y. Neurophysiological comparisons of subthalamic deep-brain stimulation for Parkinson's disease between patients receiving general and local anesthesia. Tzu Chi Medical Journal 2016, 28, 63-67.
    53. LaHue, S.C.; Ostrem, J.L.; Galifianakis, N.B.; San Luciano, M.; Ziman, N.; Wang, S.; Racine, C.A.; Starr, P.A.; Larson, P.S.; Katz, M. Parkinson's disease patient preference and experience with various methods of DBS lead placement. Parkinsonism & Related Disorders 2017, 41, 25-30.
    54. Yamada, K.; Goto, S.; Kuratsu, J.; Matsuzaki, K.; Tamura, T.; Nagahiro, S.; Murase, N.; Shimazu, H.; Kaji, R. Stereotactic surgery for subthalamic nucleus stimulation under general anesthesia: a retrospective evaluation of Japanese patients with Parkinson's disease. Parkinsonism Relat Disord 2007, 13, 101-107, doi:10.1016/j.parkreldis.2006.07.008.
    55. Chen, S.Y.; Tsai, S.T.; Lin, S.H.; Chen, T.Y.; Hung, H.Y.; Lee, C.W.; Wang, W.H.; Chen, S.P.; Lin, S.Z. Subthalamic deep brain stimulation in Parkinson's disease under different anesthetic modalities: a comparative cohort study. Stereotact Funct Neurosurg 2011, 89, 372-380, doi:10.1159/000332058.
    56. Asha, M.J.; Fisher, B.; Kausar, J.; Garratt, H.; Krovvidi, H.; Shirley, C.; White, A.; Chelvarajah, R.; Ughratdar, I.; Hodson, J.A. Subthalamic deep brain stimulation under general anesthesia and neurophysiological guidance while on dopaminergic medication: comparative cohort study. Acta neurochirurgica 2018, 160, 823-829.
    57. Lettieri, C.; Rinaldo, S.; Devigili, G.; Pauletto, G.; Verriello, L.; Budai, R.; Fadiga, L.; Oliynyk, A.; Mondani, M.; D'Auria, S., et al. Deep brain stimulation: Subthalamic nucleus electrophysiological activity in awake and anesthetized patients. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2012, 123, 2406-2413, doi:10.1016/j.clinph.2012.04.027.
    58. Maltête, D.; Navarro, S.; Welter, M.-L.; Roche, S.; Bonnet, A.-M.; Houeto, J.-L.; Mesnage, V.; Pidoux, B.; Dormont, D.; Cornu, P. Subthalamic stimulation in Parkinson disease: with or without anesthesia? Archives of neurology 2004, 61, 390-392.
    59. Brodsky, M.A.; Anderson, S.; Murchison, C.; Seier, M.; Wilhelm, J.; Vederman, A.; Burchiel, K.J. Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease. Neurology 2017, 89, 1944-1950, doi:10.1212/wnl.0000000000004630.
    60. Sharma, M.; Deogaonkar, M. Accuracy and safety of targeting using intraoperative "O-arm" during placement of deep brain stimulation electrodes without electrophysiological recordings. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2016, 27, 80-86, doi:10.1016/j.jocn.2015.06.036.
    61. Carlson, J.D.; McLeod, K.E.; McLeod, P.S.; Mark, J.B. Stereotactic Accuracy and Surgical Utility of the O-Arm in Deep Brain Stimulation Surgery. Oper Neurosurg (Hagerstown) 2017, 13, 96-107, doi:10.1227/neu.0000000000001326.
    62. Sillay, K.A.; Rusy, D.; Buyan-Dent, L.; Ninman, N.L.; Vigen, K.K. Wide-bore 1.5 T MRI-guided deep brain stimulation surgery: initial experience and technique comparison. Clin Neurol Neurosurg 2014, 127, 79-85, doi:10.1016/j.clineuro.2014.09.017.
    63. Aviles-Olmos, I.; Kefalopoulou, Z.; Tripoliti, E.; Candelario, J.; Akram, H.; Martinez-Torres, I.; Jahanshahi, M.; Foltynie, T.; Hariz, M.; Zrinzo, L. Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach. J Neurol Neurosurg Psychiatry 2014, 85, 1419-1425.
    64. Chabardes, S.; Isnard, S.; Castrioto, A.; Oddoux, M.; Fraix, V.; Carlucci, L.; Payen, J.F.; Krainik, A.; Krack, P.; Larson, P. Surgical implantation of STN-DBS leads using intraoperative MRI guidance: technique, accuracy, and clinical benefit at 1-year follow-up. Acta neurochirurgica 2015, 157, 729-737.
    65. Spiegelmann, R.; Nissim, O.; Daniels, D.; Ocherashvilli, A.; Mardor, Y. Stereotactic targeting of the ventrointermediate nucleus of the thalamus by direct visualization with high-field MRI. Stereotactic and functional neurosurgery 2006, 84, 19-23.
    66. Lee, P.S.; Richardson, R.M. Interventional MRI-Guided Deep Brain Stimulation Lead Implantation. Neurosurg Clin N Am 2017, 28, 535-544, doi:10.1016/j.nec.2017.05.007.
    67. Min, H.K.; Ross, E.K.; Lee, K.H.; Dennis, K.; Han, S.R.; Jeong, J.H.; Marsh, M.P.; Striemer, B.; Felmlee, J.P.; Lujan, J.L., et al. Subthalamic nucleus deep brain stimulation induces motor network BOLD activation: use of a high precision MRI guided stereotactic system for nonhuman primates. Brain stimulation 2014, 7, 603-607, doi:10.1016/j.brs.2014.04.007.
    68. Kochanski, R.B.; Sani, S. Awake versus Asleep Deep Brain Stimulation Surgery: Technical Considerations and Critical Review of the Literature. Brain Sci 2018, 8, doi:10.3390/brainsci8010017.
    69. Kamiryo, T.; Laws, E.R., Jr. Stereotactic frame-based error in magnetic-resonance-guided stereotactic procedures: a method for measurement of error and standardization of technique. Stereotact Funct Neurosurg 1996, 67, 198-209, doi:10.1159/000099448.
    70. Ko, A.L.; Ibrahim, A.; Magown, P.; Macallum, R.; Burchiel, K.J. Factors affecting stereotactic accuracy in image-guided deep brain stimulator electrode placement. Stereotactic and Functional Neurosurgery 2017, 95, 315-324.
    71. Chen, T.; Mirzadeh, Z.; Chapple, K.; Lambert, M.; Dhall, R.; Ponce, F.A. “Asleep” deep brain stimulation for essential tremor. Journal of neurosurgery 2016, 124, 1842-1849.
    72. Holloway, K.; Docef, A. A quantitative assessment of the accuracy and reliability of O-arm images for deep brain stimulation surgery. Neurosurgery 2013, 72, 47-57, doi:10.1227/NEU.0b013e318273a090.
    73. Geevarghese, R.; O'Gorman Tuura, R.; Lumsden, D.E.; Samuel, M.; Ashkan, K. Registration Accuracy of CT/MRI Fusion for Localisation of Deep Brain Stimulation Electrode Position: An Imaging Study and Systematic Review. Stereotact Funct Neurosurg 2016, 94, 159-163, doi:10.1159/000446609.
    74. Ivan, M.E.; Yarlagadda, J.; Saxena, A.P.; Martin, A.J.; Starr, P.A.; Sootsman, W.K.; Larson, P.S. Brain shift during bur hole-based procedures using interventional MRI. J Neurosurg 2014, 121, 149-160, doi:10.3171/2014.3.jns121312.
    75. Deuschl, G.; Schade-Brittinger, C.; Krack, P.; Volkmann, J.; Schäfer, H.; Bötzel, K.; Daniels, C.; Deutschländer, A.; Dillmann, U.; Eisner, W. A randomized trial of deep-brain stimulation for Parkinson's disease. New England Journal of Medicine 2006, 355, 896-908.
    76. Erickson, K.M.; Cole, D.J. Anesthetic considerations for awake craniotomy for epilepsy. Anesthesiology clinics 2007, 25, 535-555, ix, doi:10.1016/j.anclin.2007.06.001.
    77. Grant, R.; Gruenbaum, S.E.; Gerrard, J. Anaesthesia for deep brain stimulation: a review. Current opinion in anaesthesiology 2015, 28, 505.
    78. Khan, M.F.; Mewes, K.; Gross, R.E.; Skrinjar, O. Assessment of brain shift related to deep brain stimulation surgery. Stereotact Funct Neurosurg 2008, 86, 44-53, doi:10.1159/000108588.
    79. Pallavaram, S.; Dawant, B.M.; Remple, M.S.; Neimat, J.S.; Kao, C.; Konrad, P.E.; D'Haese, P.F. Effect of brain shift on the creation of functional atlases for deep brain stimulation surgery. International journal of computer assisted radiology and surgery 2010, 5, 221-228, doi:10.1007/s11548-009-0391-1.
    80. Elias, W.J.; Durieux, M.E.; Huss, D.; Frysinger, R.C. Dexmedetomidine and arousal affect subthalamic neurons. Movement disorders 2008, 23, 1317-1320.
    81. Pollak, P.; Krack, P.; Fraix, V.; Mendes, A.; Moro, E.; Chabardes, S.; Benabid, A.L. Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson's disease. Mov Disord 2002, 17 Suppl 3, S155-161, doi:10.1002/mds.10158.
    82. Gorgulho, A.; De Salles, A.A.; Frighetto, L.; Behnke, E. Incidence of hemorrhage associated with electrophysiological studies performed using macroelectrodes and microelectrodes in functional neurosurgery. Journal of neurosurgery 2005, 102, 888-896.
    83. Binder, D.K.; Rau, G.M.; Starr, P.A. Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery 2005, 56, 722-732.
    84. Vesper, J.; Haak, S.; Ostertag, C.; Nikkhah, G. Subthalamic nucleus deep brain stimulation in elderly patients--analysis of outcome and complications. BMC Neurol 2007, 7, 7, doi:10.1186/1471-2377-7-7.
    85. Guridi, J.; Rodriguez-Oroz, M.C.; Lozano, A.M.; Moro, E.; Albanese, A.; Nuttin, B.; Gybels, J.; Ramos, E.; Obeso, J.A. Targeting the basal ganglia for deep brain stimulation in Parkinson's disease. Neurology 2000, 55, S21-28.
    86. Houeto, J.-L.; Welter, M.-L.; Bejjani, P.-B.; du Montcel, S.T.; Bonnet, A.-M.; Mesnage, V.; Navarro, S.; Pidoux, B.; Dormont, D.; Cornu, P. Subthalamic stimulation in Parkinson disease: intraoperative predictive factors. Archives of neurology 2003, 60, 690-694.
    87. Blasberg, F.; Wojtecki, L.; Elben, S.; Slotty, P.J.; Vesper, J.; Schnitzler, A.; Groiss, S.J. Comparison of Awake vs. Asleep Surgery for Subthalamic Deep Brain Stimulation in Parkinson's Disease. Neuromodulation 2018, 21, 541-547, doi:10.1111/ner.12766.
    88. Castrioto, A.; Marmor, O.; Deffains, M.; Willner, D.; Linetsky, E.; Bergman, H.; Israel, Z.; Eitan, R.; Arkadir, D. Anesthesia reduces discharge rates in the human pallidum without changing the discharge rate ratio between pallidal segments. European Journal of Neuroscience 2016, 44, 2909-2913.
    89. Moll, C.K.; Payer, S.; Gulberti, A.; Sharrott, A.; Zittel, S.; Boelmans, K.; Köppen, J.; Gerloff, C.; Westphal, M.; Engel, A.K. STN stimulation in general anaesthesia: evidence beyond ‘evidence-based medicine’. In Stereotactic and Functional Neurosurgery, Springer: 2013; pp. 19-25.
    90. Sanghera, M.K.; Grossman, R.G.; Kalhorn, C.G.; Hamilton, W.J.; Ondo, W.G.; Jankovic, J. Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomy. Neurosurgery 2003, 52, 1358-1373.
    91. Tsai, S.T.; Chuang, W.Y.; Kuo, C.C.; Chao, P.C.; Chen, T.Y.; Hung, H.Y.; Chen, S.Y. Dorsolateral subthalamic neuronal activity enhanced by median nerve stimulation characterizes Parkinson's disease during deep brain stimulation with general anesthesia. J Neurosurg 2015, 123, 1394-1400, doi:10.3171/2014.11.JNS141208.
    92. Kim, W.; Song, I.H.; Lim, Y.H.; Kim, M.-R.; Kim, Y.E.; Hwang, J.H.; Kim, I.K.; Song, S.W.; Kim, J.W.; Lee, W.-W. Influence of propofol and fentanyl on deep brain stimulation of the subthalamic nucleus. Journal of Korean medical science 2014, 29, 1278-1286.
    93. Lee, W.-W.; Ehm, G.; Yang, H.-J.; Song, I.H.; Lim, Y.H.; Kim, M.-R.; Kim, Y.E.; Hwang, J.H.; Park, H.R.; Lee, J.M. Bilateral deep brain stimulation of the subthalamic nucleus under sedation with propofol and fentanyl. PLoS One 2016, 11, e0152619.
    94. Galvan, A.; Wichmann, T. GABAergic circuits in the basal ganglia and movement disorders. Progress in brain research 2007, 160, 287-312.
    95. Raz, A.; Eimerl, D.; Zaidel, A.; Bergman, H.; Israel, Z. Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients. Anesthesia & Analgesia 2010, 111, 1285-1289.
    96. Lin, S.-H.; Chen, T.-Y.; Lin, S.-Z.; Shyr, M.-H.; Chou, Y.-C.; Hsieh, W.A.; Tsai, S.-T.; Chen, S.-Y. Subthalamic deep brain stimulation after anesthetic inhalation in Parkinson disease: a preliminary study. Journal of neurosurgery 2008, 109, 238-244.
    97. Lin, S.H.; Lai, H.Y.; Lo, Y.C.; Chou, C.; Chou, Y.T.; Yang, S.H.; Sun, I.; Chen, B.W.; Wang, C.F.; Liu, G.T., et al. Decreased Power but Preserved Bursting Features of Subthalamic Neuronal Signals in Advanced Parkinson's Patients under Controlled Desflurane Inhalation Anesthesia. Front Neurosci 2017, 11, 701, doi:10.3389/fnins.2017.00701.
    98. Kouvaras, E.; Asprodini, E.K.; Asouchidou, I.; Vasilaki, A.; Kilindris, T.; Michaloudis, D.; Koukoutianou, I.; Papatheodoropoulos, C.; Kostopoulos, G. Fentanyl treatment reduces GABAergic inhibition in the CA1 area of the hippocampus 24 h after acute exposure to the drug. Neuropharmacology 2008, 55, 1172-1182, doi:10.1016/j.neuropharm.2008.07.025.
    99. Hutchison, W.D.; Lang, A.E.; Dostrovsky, J.O.; Lozano, A.M. Pallidal neuronal activity: implications for models of dystonia. Ann Neurol 2003, 53, 480-488, doi:10.1002/ana.10474.
    100. Khatib, R.; Ebrahim, Z.; Rezai, A.; Cata, J.P.; Boulis, N.M.; John Doyle, D.; Schurigyn, T.; Farag, E. Perioperative events during deep brain stimulation: the experience at cleveland clinic. Journal of neurosurgical anesthesiology 2008, 20, 36-40, doi:10.1097/ANA.0b013e318157a15a.
    101. Duque, P.; Mateo, O.; Ruiz, F.; de Viloria, J.G.; Contreras, A.; Grandas, F. Intraoperative microrecording under general anaesthesia with bispectral analysis monitoring in a case of deep brain stimulation surgery for Parkinson's disease. European journal of neurology 2008, 15, e76-77, doi:10.1111/j.1468-1331.2008.02166.x.
    102. Lee, J.Y.; Deogaonkar, M.; Rezai, A. Deep brain stimulation of globus pallidus internus for dystonia. Parkinsonism Relat Disord 2007, 13, 261-265, doi:10.1016/j.parkreldis.2006.07.020.
    103. Morace, R.; De Angelis, M.; Aglialoro, E.; Maucione, G.; Cavallo, L.; Solari, D.; Modugno, N.; Santilli, M.; Esposito, V.; Aloj, F. Sedation with α2 Agonist Dexmedetomidine During Unilateral Subthalamic Nucleus Deep Brain Stimulation: A Preliminary Report. World Neurosurg 2016, 89, 320-328, doi:10.1016/j.wneu.2016.01.037.
    104. Rozet, I. Anesthesia for functional neurosurgery: the role of dexmedetomidine. Curr Opin Anaesthesiol 2008, 21, 537-543, doi:10.1097/ACO.0b013e32830edafd.
    105. Sassi, M.; Zekaj, E.; Grotta, A.; Pollini, A.; Pellanda, A.; Borroni, M.; Pacchetti, C.; Menghetti, C.; Porta, M.; Servello, D. Safety in the use of dexmedetomidine (precedex) for deep brain stimulation surgery: our experience in 23 randomized patients. Neuromodulation 2013, 16, 401-406; discussion 406, doi:10.1111/j.1525-1403.2012.00483.x.
    106. Hans, P.; Bonhomme, V.; Born, J.D.; Maertens de Noordhoudt, A.; Brichant, J.F.; Dewandre, P.Y. Target-controlled infusion of propofol and remifentanil combined with bispectral index monitoring for awake craniotomy. Anaesthesia 2000, 55, 255-259, doi:10.1046/j.1365-2044.2000.01277.x.
    107. Johansen, J.W.; Sebel, P.S. Development and clinical application of electroencephalographic bispectrum monitoring. Anesthesiology 2000, 93, 1336-1344, doi:10.1097/00000542-200011000-00029
    More